Virtual Medicinal Product (VMP)
-
Mometasone 50micrograms/dose nasal spray
Name Details
Current Name
Mometasone 50micrograms/dose nasal spray
|
Start Date
16-08-2006
|
End Date
|
Previous Name
Mometasone 50micrograms/actuation nasal spray
|
Start Date
24-11-2002
|
End Date
15-08-2006
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- dose
- Unit Dose UOM
- dose
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Nasal
- Form
- Spray
- Ontology Form/Route
- suspensionspray.nasal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
R01AD09
BNF |
Current BNF
12020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
12020100
|
Start Date
17-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
39109911000001109 |
21-10-2020 |
|
331080007 |
24-11-2002 |
20-10-2020 |
VMP Ingredients
VMP ingredients table
Mometasone furoate |
Based on Ingredient Substance |
|
50 microgram |
1 dose |
Name
Mometasone furoate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Mometasone
-
VMP
(Current) Mometasone 50micrograms/dose nasal s...
Virtual Medicinal Product Pack (VMPP) Information